EWA
HRMY icon

EverSource Wealth Advisors’s Harmony Biosciences HRMY Stock Holding History

EverSource Wealth Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Sell
402
-20
-5% -$631 ﹤0.01% 2663
2026
Q1 		$11.8K Sell
422
-330
-44% -$10.8K ﹤0.01% 2826
2025
Q4 		$28.1K Buy
752
+643
+590% +$21.1K ﹤0.01% 2158
2025
Q3 		$3K Sell
109
-193
-64% -$6.65K ﹤0.01% 3374
2025
Q2 		$9.54K Buy
302
+178
+144% +$5.73K ﹤0.01% 2836
2025
Q1 		$4.12K Sell
124
-8
-6% -$287 ﹤0.01% 2587
2024
Q4 		$4.54K Buy
132
+43
+48% +$1.48K ﹤0.01% 2393
2024
Q3 		$3.56K Buy
89
+50
+128% +$1.76K ﹤0.01% 2354
2024
Q2 		$1.32K Hold
39
– – ﹤0.01% 2667
2024
Q1 		$1.21K Hold
39
– – ﹤0.01% 2524
2023
Q4 		$1.26K Buy
+39
New +$1.09K ﹤0.01% 2320

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EverSource Wealth Advisors's HRMY Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Harmony Biosciences (HRMY) stake by 4.7% in Q2 2026, selling an estimated $631 and leaving 402 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

EverSource Wealth Advisors first reported a position in HRMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $28.1K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • EverSource Wealth Advisors held 402 shares of Harmony Biosciences worth $14.6K as of Q2 2026.
  • EverSource Wealth Advisors sold 20 Harmony Biosciences shares in Q2 2026, an estimated $631.
  • Harmony Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2663 holding.
  • EverSource Wealth Advisors first reported a position in Harmony Biosciences in Q4 2023 and has held it in 11 quarters since.
  • EverSource Wealth Advisors's Harmony Biosciences position peaked at $28.1K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.